The purpose of Sermorelin Acetate Therapy causes the pituitary gland to increase growth hormone production in humans. HRT Max Health's objective, in providing physician-supervised, adult Sermorelin growth hormone therapy, is to reverse the negative effects of aging and secure the extensive treatment benefits described below. HRT Max Health believes finding the right dosage of Sermorelin can provide identical benefits to HGH therapy as the end result is elevated human growth hormone (hGH) levels in our clients.
What is Sermorelin Acetate GH-RH?
Sermorelin Acetate is a "growth hormone-releasing hormone" (GHRH). This prescription drug is compounded by U.S. pharmacies pursuant to our physician's prescription and is patient self-injected subcutaneously. It stimulates the pituitary gland to naturally produce increased amounts of human growth hormone. Sermorelin Acetate is a truncated analog of a growth hormone releasing factor (GRF 1-44) that is naturally produced by the brain to stimulate pituitary production of human growth hormone. The increased volume of human growth hormone (hGH) produced by the pituitary gland causes an increase in the production of Insulin-Like Growth Factor-1 (IGF-1) by the liver and results in the benefits of treatment provided to the adult patient.
As a result of Sermorelin Growth Hormone (GHRH) Therapy, the increased volume of human growth hormone (hGH) secreted by the stimulated pituitary gland is converted by the liver into IGF-1. The increased amount of IGF-1 in the blood stream results an increase in metabolism and growth of new cells within the body's organs and bones. This treatment is prescribed for unlabeled use in adults to increase lean muscle mass, reduce body fat, increase bone density, enhance the immune system, and strengthen the heart, as well as, other organs of the body. Since the increased volume of human growth hormone is produced by the body's pituitary gland, the body's endocrine system will not allow more growth hormone to be produced by the Sermorelin GH-RH stimulation of the pituitary than the body can safely process within the endocrine self-monitoring system.
Sermorelin Acetate Growth Hormone - Releasing Hormone has been specifically approved for medical use in increasing growth hormone levels in children deficient in growth hormone production. Its use to increase the growth hormone and IGF-1 levels in adults is an off-label use of this prescription drug.
Sermorelin Acetate Growth Hormone - Releasing Hormone Therapy causes the pituitary gland to increase the growth hormone and IGF-1 levels in humans. It is a prescription drug approved for one medical use that may be prescribed for adults for other unlabeled medical uses that are determined by the treating physician to be indicated and appropriate.
HGH or Human Growth Hormone Therapy and Sermorelin Acetate Growth Hormone Releasing Hormone Therapy Provide Similar Treatment Benefits
Human growth hormone therapy and Sermorelin therapy have substantially the same treatment benefits because injected recombinant human growth hormone (somatropin) medication is genetically engineered to have the same DNA structure as human growth hormone produced by the pituitary gland when stimulated by Sermorelin injections. The benefits of Sermorelin therapy or recombinant human growth hormone therapy include the following:
Sermorelin Growth Hormone Releasing Hormone (GH-RH) Therapy Is Less Than Half the Cost of Recombinant Human Growth Hormone (Somatropin) Therapy
The cost of Sermorelin therapy is typically less than one half the cost of recombinant human growth hormone (somatropin) therapy due to the higher cost of the genetically engineered human growth hormone medication.